Skip to content
Search

Latest Stories

UK officials publish "priority pathogen" watch list

 UK priority pathogen watch list for public health safety.

Researchers hope the list will speed up vaccine and diagnostics development

Pic credit: iStock

UK officials published a watch list of 24 "priority pathogen" families on Tuesday, hoping to boost readiness in case another public health crisis strikes.

The UK Health Security Agency's guide is designed to help researchers focus their efforts on certain viruses and bacteria that pose a threat to public health, as well as speed up the development of vaccines.


Pathogen families on the list include coronaviridae, which includes Covid-19, paramyxoviridae, which includes Nipah virus, and orthomyxoviridae, which includes bird flu. Ebola, norovirus and mpox are also listed.

The agency's chief scientific officer Isabel Oliver said it was "a vital guide for industry and academia, highlighting where scientific research can be targeted to boost UK preparedness against health threats."

"We hope this will help to speed up vaccine and diagnostics development where it is most needed, to ensure we are fully prepared in our fight against potentially deadly pathogens."

Five years since the start of the global Covid-19 pandemic, emotions still run raw across the UK with lingering accusations that the then government responded too slowly to the crisis.

According to the WHO, more than 232,000 people have died with Covid in the United Kingdom.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
RPS transition to Royal College

RPS transition to Royal College: What it means for pharmacy

RPS transition to Royal College: What it means for pharmacy - Professor Claire Anderson explains

The Royal Pharmaceutical Society (RPS) is set to transition into a Royal College after securing majority support from its members in a recent ballot. However, concerns have been raised about the long-term implications of this shift.

With a voter turnout of 31.4%, 6,144 out of 19,594 eligible members participated in the vote on the Royal Charter changes. Of those, 71.1% supported the transition, well above the required two-thirds majority for a Special Resolution Vote.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
Community pharmacy must now focus on matters in their direct control

The new Community Pharmacy Contractual Framework is a step in the right direction - Victoria Steele

Victoria Steele

Community pharmacy shouldn’t rely solely on CPCF income

Over the coming days much will be/is being written about the Community Pharmacy Contractual Framework and the Independent Economic Review. Emotions are understandably high this week and as everyone has already said, the devil is in the detail.

I must admit to being puzzled by the behaviours that I’m witnessing, and energy being expended at Community Pharmacy England’s door rather than that of government. Only those in the room whilst negotiating will know what information they were dealing with and as is always the case in these situations, they (CPE) are undoubtedly in an unenviable position where nothing they could do would have been right (or certainly not enough).

Keep ReadingShow less
A Royal College of Pharmacy

A Royal College of Pharmacy will aim to have a united voice

Pic credit: iStock

A Royal College of Pharmacy:  The what, the why and the how

By Mike Holden,

The what

Keep ReadingShow less